Clinical Trial Update: Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gallium-68-HBED-CC-PSMA imaging in prostate cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gallium-68-HBED-CC-PSMA imaging

Snippet

Sponsor: Thomas Hope | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-22